1Judith Jansen, Wolfram Karges, Lothar Rink. Zinc and diabetesclinical links and molecular mechanisms[ J]. Journal of Nutritional Biochemistry ,2009,20:399 - 417.
2Daneman D. Type 1 diabetes [J]. Lancet,2006,367 : 847 - 858.
3AI -Maroof RA ,Al-Sharbatti SS. Serum zinc levels in diabetic patients and effect of zinc supplementation on glycemic control of type 2 diabetics[J]. Saudi Med J,2006,27 : 344 - 50.
5Michael F. Dunn. Zinc-ligand interactions modulate assembly and stability of the insulin hexamer-a review [J]. B io Metals,2005,18 : 295 - 3O3.
6Angelo Avogaro, Saula Vigili de Kreutzenberg, Gian Paolo Fadini. Insulin signaling and life span [ J ]. Pflugers Arch Eur J Physiol, 2010,459:301 - 314.
7Sarah G. Paule a,Biljana Nikolovski a,Justin Ludeman a,et al. Ability of GHTD-amide and analogs to enhance insulin activity through zinc chelation and dispersal of insulin oligomers [ J ]. Peptides ,2009,30 : 1088 - 1097.
8Haase H, Maret W. Protein tyrosine phosphatases as targets of the combined insu|inomimetic effects of zinc and oxidants[ J]. Biometals ,2005,18:333 - 338.
9Chiara Ciaccio,Grazia R. Tundo,Giuseppe Grasso,et al. Somatostatin:A Novel Substrate and a Modulator of Insulin-Degrading Enzyme Activity[J]. J Mol Biol,2009,385 : 1556 - 1567.
10Schubert M, Gautam D, Surjo D, et al. Role for neuronal insulin resistance in neurodegenerative diseases[ J ]. Proc Natl Acad Sci USA ,2004,101:3100 - 3105.
2DUNN M F. Zinc-ligand interactions modulate assembly and stability of the insulin hexamer-a review [ J ].Biometals, 2005,18 (4) : 295-303.
3FAURE P. Protective effects of antioxidant micronutrients (vitamin E, zinc and selenium) in type 2 diabetes mellitus[J]. Clin Chem Lab Med,2003,41 (8):995-998.
4YOSHIKAWA Y, KONDO M, SAKURAI H. A family of insulinomimetic zinc( Ⅱ ) complexes of amino ligands with Zn(Nn) (n = 3 and 4) coordination modes[J]. J Inorg Biochem ,2005,99(7) : 1497-1503.
5ADACHI Y, YOSHIDA J, KODERA Y. A new insulinmimetic bis ( allixinato ) zinc ( Ⅱ ) complex: structureactivity relationship of zinc ( Ⅱ ) complexes [ J ]. J Biol Inorg Chem,2004,9(7) :115-193.
6AL-MAROOF R A, Al-SHARBATTI S S. Serum zinc levels in diabetic patients and effect of zinc supplementation on glycemic control of type 2 diabetics[J]. Saudi Med J, 2006,27(3) :344-350.
7PARTIDA-HERNANDEZ G, ARREOLA F, FENTON B,et al. Effect of zinc replacement on lipids and lipoproteins in type 2-diabetic patients [ J ]. Biomed Pharmacother,2006, 60(4) :161-168.
8VINCENT J B. Mechanisms of chromium action: lowmolecular-weight chromium-binding substance [ J ]. J Am Coll Nutr, 1999,18(1) :6-12.
9DAVIS C M, VINCENT J B. Chromium oligopeptide activates insulin receptor tyrosine kinase activity [ J ].Biochem, 1997,36(15) :4382-4385.
10ANDERSON R A, POLANSKY M M, BRKDEN N A, et al. Chromium supplementation of human subject : effect on glucose tolerance, serum glucose, insulin, and lipid variables[J]. Metabolism, 1983,32(9) :894-899.
